Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma

被引：0
|
作者：
Gerali, S [1 ]
Koutsikos, J [1 ]
Tsiouris, S [1 ]
Mainta, E [1 ]
Lucchetti, S [1 ]
Papathanasiou, G [1 ]
Fotinaki, E [1 ]
Makripoulias, V [1 ]
Kotsias, D [1 ]
Palestidis, C [1 ]
Zerva, C [1 ]
机构：
[1] Alexandra Univ Hosp, Dept Nucl Med, Athens, Greece
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2004年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S425 / S425
页数：1
相关论文
共 50 条
  • [1] Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma
    Zerva, C.
    Koutsikos, J.
    Palestidis, C.
    Kounadi, E.
    Gerali, S.
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 50 (04): : 348 - 354
  • [2] The value of detectable thyroglobulin in patients with differentiated thyroid cancer after initial 131I therapy
    van Dijk, D.
    Plukker, J. T. M.
    van der Horst-Schrivers, A. N. A.
    Jansen, L.
    Brouwers, A. H.
    Muller-Kobold, A.
    Sluiter, W. J.
    Links, T. P.
    [J]. CLINICAL ENDOCRINOLOGY, 2011, 74 (01) : 104 - 110
  • [3] Prognostic Value of Thyroglobulin Levels and Therapeutic 131I Whole-Body Scan after Initial 131I Ablation of Differentiated Thyroid Cancer
    Luo, Q.
    Yu, Y.
    Lu, H.
    Zhu, R.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S241 - S241
  • [4] Advantages of dosimetry in 131I therapy of differentiated thyroid carcinoma
    Verburg, Frederik A.
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 63 (03): : 253 - 257
  • [5] Prognostic value of serial 131I scans in patinets with differentiated thyroid cancer after 131I therapy.
    Lu, HK
    Zhu, RS
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 410P - 410P
  • [6] Analysis of the 131I therapy in the young and adolescent patients with differentiated thyroid carcinoma
    Wang, Jiantao
    Kuang, Anren
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [7] Radiodine uptake in thyroid remnants in patients with differentiated thyroid cancer:: A comparison between very-low 131I diagnostic dose and high 131I therapy activities
    Azevedo-Silva, F.
    Cavaco, A.
    Freitas, D.
    Isidoro, J.
    Vieira, F.
    Costa, G.
    Pedroso-Lima, J.
    Ferrer-Antunes, A. I.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S230 - S230
  • [8] 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma
    Toubeau, M
    Touzery, C
    Berriolo-Riedinger, A
    Cochet, A
    Brunotte, F
    Bedenne, L
    Cercueil, JP
    Krause, D
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (05) : 669 - 670
  • [9] 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma
    Michel Toubeau
    Claude Touzery
    Alina Berriolo-Riedinger
    Alexandre Cochet
    François Brunotte
    Laurent Bedenne
    Jean-Pierre Cercueil
    Denis Krause
    [J]. European Journal of Nuclear Medicine, 2001, 28 : 669 - 670
  • [10] Implications of mediastinal uptake of 131I with regard to surgery in patients with differentiated thyroid carcinoma
    Haveman, JW
    Phan, HTT
    Links, TP
    Jager, PL
    Plukker, JTM
    [J]. CANCER, 2005, 103 (01) : 59 - 67
12345